Abstract:Cocaine is a highly psychoactive substance with numerous effects that readily crosses the placenta, achieving variables levels in the fetus. Determining whether prenatal exposure to cocaine and its metabolites damages the developing human nervous system is hindered by the multiple intervening factors (confounders) that plague clinical settings, which warrant consideration in controlled studies. Prenatal cocaine exposure has been linked to numerous adverse neonatal outcomes, affecting fetal growth (i.e., low birth weight, intrauterine growth retardation, and small head size) and neurobehavior. These neurobehavior effects span the gamut from no abnormalities to impairments in arousal, neurological function, neurophysiological function, and state regulation. Strokes and possibly seizures are also noted. Dose-response effects of fetal cocaine exposure on fetal growth and neonatal neurobehavior are reported using quantitative methods of ascertainment. In early infancy, irritability and hypertonia are also described. Most cocaine associations are transient and resolve in infancy and early childhood. Whether such transient abnormalities place infants at increased risk for later neurodevelopmental impairments is not known. Controlled studies have found no cognitive differences related to prenatal cocaine exposure among toddlers or school age children, except as mediated through effects on head growth. Anecdotally, cocaine-exposed children seem to suffer from neurobehavioral abnormalities, but to date controlled studies have not established an association between cocaine and behavioral disorders, except for inattentiveness. Despite encouraging reports, the question of whether cocaine exerts long-term adverse effects on the developing human nervous system has not yet been resolved, largely because of the limitations of existing studies that rely on inadequate, mostly qualitative ascertainment of cocaine exposure as well as the dearth of studies in older children. Such methodological limitations may have compromised our ability to identify cocaine-exposed children at most risk.

Neurological and systemic effects of cocaine toxicity: A case report and review of the literature

Neurovascular effects of cocaine: relevance to addiction

Cocaine-induced agitated delirium: a case report and review

An Empirical Comparison of Accounting Information Representations (Research-in- Progress)

Narrative Review of Heart Failure Related to Cocaine Consumption and Its Therapeutic Management

Cardiac Arrest (CA) as the Initial Presentation of Cocaine-Induced Takotsubo Cardiomyopathy (TCM): A Case Report and Review of Literature

Psychosis in cocaine intoxication

Cellular and molecular responses to acute cocaine treatment in neuronal-like N2a cells: potential mechanism for its resistance in cell death

An Interpretative Model

Abstract TP261: Cocaine Use on Patients With Acute Ischemic Stroke: Classification of Subtype, Management, and Clinical Outcomes

NO-induced reversible switching of the electronic interaction between a porphyrin-coordinated cobalt ion and a silver surface.

Platelets promote bacterial dissemination in a mouse model of streptococcal sepsis.

Orbital Complication in the Setting of Cocaine Use: A Case Report and Review of Literature

Lidocaine-Associated CNS Toxicity at Therapeutic Dosage: A Case Report and Literature Review

Neurological Effects of Stimulants and Hallucinogens

Transient Neurogenic Bowel Dysfunction in a Case of Cocaine-Induced Spinal Cord Infarction

Cerebellar Leukoencephalopathy following Fentanyl Intoxication. A case report and review of the literature

Cocaine-induced Movement Disorder: A Literature Review

Cocaine/levamisole-induced systemic vasculitis with retiform purpura and pauci-immune glomerulonephritis

Characteristic Cardiac Magnetic Resonance (CMR) Imaging Findings of Cocaine-Induced Myocardial Injury

Neurological correlates of fetal cocaine exposure